For Sponsors / CROs

Your Dedicated Research Partner

Our Capabilities

Recruitment:

Bilingual (English/Spanish) Recruitment Team
Database of 300,000 searchable patients
Consistent recruitment rate of 94%
Consistent retention rate of over 90%
Access to Tampa Bay metro population of > 3 million

Operations:

Dedicated and embedded research clinics
Multi-therapeutic phase 1b-IV capabilities
PPM- CLIA Licensure as well as Local Lab partnerships
GCP, OHRP, HIPAA, BLS, ACLS and IATA certified staff
RNs, LPNs, Medical Assistants and Pharmacy Techs

Technology:

Part 11 compliant CTMS, eConsent, eRegulatory and eSource systems
Virtual study visit capable
VersaTrial software for study portal organization and management
Experience with most EDC, IWRS/IVRS systems
Remote monitoring capable for all studies

Equipment:

InTemp WIFI temperature data logger system for ambient, refrigeration and freezer storage
Safety equipment includes crash carts, emergency meds, oxygen and defibrillators
Laminar flow hood for drug preparation and safety
Centrifuges, minus 20 and minus 80 freezers, commercial refrigerators
PBMC Processing, with an accredited vendor
Power loss Generator and Battery Backup Vaccine refrigerator

Therapeutic Areas

Consistently delivering positive results over a variety of indications.

COVID-19 BOOSTER VACCINE STUDY

Enrollment Goal: 40

Actual Enrollment: 108

0%

Enrollment Rate: 270%

0%

Retention Rate 96%

0%

Enrollment Timeline:

12 Weeks

ACNE VULGARIS STUDY

(Single Site, 3 Locations)

Enrollment Goal: 570

Actual Enrollment: 575

0%

Enrollment Rate: 101%

0%

Retention Rate 90%

0%

Enrollment Timeline:

12 Weeks

COVID-19 TREATMENT STUDY

Enrollment Goal: 30

Actual Enrollment: 52

0%

Enrollment Rate: 173%

0%

Retention Rate 93%

0%

Enrollment Timeline:

16 Weeks

GLUCOSE MONITOR
DEVICE STUDY

Enrollment Goal: 207

Actual Enrollment: 207

0%

Enrollment Rate: 100%

0%

Retention Rate 100%

0%

Enrollment Timeline:

12 Weeks

TINEA PEDIS STUDY

Enrollment Goal: 25

Actual Enrollment: 31

0%

Enrollment Rate: 124%

0%

Retention Rate 97%

0%

Enrollment Timeline:

10 Weeks

PLAQUE PSORIASIS STUDY

(Pilot study / Rescue Site)

Enrollment Goal: 3

Actual Enrollment: 9

0%

Enrollment Rate: 300%

0%

Retention Rate 100%

0%

Enrollment Timeline:

2 Weeks

Patient Inclusion Data

For more information on our services, please get in contact with:

Jeffrey Smyth, MS

President & Executive Director

Partnerships

4257 West Kennedy Blvd
Tampa, FL 33609

Phone: (813) 948-7550
Fax: (813) 948-7566

About

Enrolling Studies

Contact

2024 © TrueBlue Clinical Research